Identification of candidate genes linking systemic inflammation to atherosclerosis; Results of a human in vivo LPS infusion study

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Sivapalaratnam, Suthesh ^a   Farrugia, Rosienne ^b   Nieuwdorp, Max ^a   Langford, Cordelia F ^c   Van Beem, Rachel T ^d   Maiwald, Stephanie ^a   Zwaginga, Jaap Jan ^d   Gusnanto, Arief ^e   Watkins, Nicholas A ^b,f   Trip, Mieke D ^a   Ouwehand, Willem H ^b,c,f  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d SANQUIN RESEARCH   (Netherlands)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Human; In Vivo; LPS infusion; Monocytes; Transcriptome

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; C3A ANAPHYLOTOXIN CHEMOTACTIC RECEPTOR; CARRIER PROTEIN; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR; PROTEIN BID; RNA; SEC61B PROTEIN; SODIUM CHLORIDE; SOLUTE CARRIER FAMILY 43 MEMBER 3; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BATF GENE; BID GENE; C3AR1 GENE; DISEASE ASSOCIATION; DNA MICROARRAY; DOWN REGULATION; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IL1RN GENE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; RNA PROCESSING; SEC61B GENE; SLC43A3 GENE; UPREGULATION; VOLUNTEER; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM;

ATHEROSCLEROSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 81155157952     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-64     Document Type: Article

References (24)

1. Systemic lupus erythematosus and cardiovascular disease. J Frostegard, Lupus 2008 17 364 367 10.1177/0961203308089988 18490408 (Pubitemid 351798708)
2. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. C Turesson, A Jarenros, L Jacobsson, Ann Rheum Dis 2004 63 952 955 10.1136/ard.2003.018101 15051620 (Pubitemid 38961920)
3. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. PA Thompson, PS Tobias, S Viriyakosol, TN Kirkland, RL Kitchens, J Biol Chem 2003 278 28367 28371 10.1074/jbc.M302921200 12754215 (Pubitemid 36935736)
4. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens, N Engl J Med 1997 336 973 979 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
5. Role of Toll-like receptors in atherosclerosis. KS Michelsen, TM Doherty, PK Shah, M Arditi, Circ Res 2004 95 96 e97 15591233
6. Inflammation in atherosclerosis. P Libby, Nature 2002 420 868 874 10.1038/nature01323 12490960 (Pubitemid 36019640)
7. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. SJ van Deventer, HR Buller, JW ten Cate, LA Aarden, CE Hack, A Sturk, Blood 1990 76 2520 2526 2124934
8. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. IC Macaulay, MR Tijssen, DC Thijssen-Timmer, A Gusnanto, M Steward, P Burns, CF Langford, PD Ellis, F Dudbridge, JJ Zwaginga, et al. Blood 2007 109 3260 3269 10.1182/blood-2006-07-036269 17192395 (Pubitemid 46572511)
9. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. A Brazma, P Hingamp, J Quackenbush, G Sherlock, P Spellman, C Stoeckert, J Aach, W Ansorge, CA Ball, HC Causton, et al. Nat Genet 2001 29 365 371 10.1038/ng1201-365 11726920 (Pubitemid 34326681)
10. ArrayExpress - a public database of microarray experiments and gene expression profiles. H Parkinson, M Kapushesky, M Shojatalab, N Abeygunawardena, R Coulson, A Farne, E Holloway, N Kolesnykov, P Lilja, M Lukk, et al. Nucleic Acids Res 2007 35 747 D750 10.1093/nar/gkl995 17132828 (Pubitemid 46056303)
11. C3aR inhibition reduces neurodegeneration in experimental lupus. A Jacob, L Bao, J Brorson, RJ Quigg, JJ Alexander, Lupus 2010 19 73 82 10.1177/0961203309348978 19900981
12. Peripheral arterial occlusive disease: global gene expression analyses suggest a major role for immune and inflammatory responses. S Fu, H Zhao, J Shi, A Abzhanov, K Crawford, L Ohno-Machado, J Zhou, Y Du, WP Kuo, J Zhang, et al. BMC Genomics 2008 9 369 10.1186/1471-2164-9-369 18673543
13. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. R Oksjoki, P Laine, S Helske, P Vehmaan-Kreula, MI Mayranpaa, P Gasque, PT Kovanen, MO Pentikainen, Atherosclerosis 2007 195 90 99 10.1016/j.atherosclerosis.2006.12.016 17234193 (Pubitemid 47561949)
14. Identification and validation of genes affecting aortic lesions in mice. X Yang, L Peterson, R Thieringer, JL Deignan, X Wang, J Zhu, S Wang, H Zhong, S Stepaniants, J Beaulaurier, et al. J Clin Invest 2010 120 2414 2422 10.1172/JCI42742 20577049
15. The effect of interleukin-1 receptor antagonist on arteries and cholesterol metabolism. K Isoda, F Ohsuzu, J Atheroscler Thromb 2006 13 21 30 10.5551/jat.13.21 16505588
16. A BATF-ling connection between B cells and follicular helper T cells. JI Ellyard, CG Vinuesa, Nat Immunol 2011 12 519 520 21587310
17. Matrix metalloproteinases and peripheral arterial disease. C Busti, E Falcinelli, S Momi, P Gresele, Intern Emerg Med 2009
18. Non-apoptotic role of BID in inflammation and innate immunity. G Yeretssian, RG Correa, K Doiron, P Fitzgerald, CP Dillon, DR Green, JC Reed, M Saleh, Nature 2011
19. The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus. YN Wang, H Yamaguchi, L Huo, Y Du, HJ Lee, HH Lee, H Wang, JM Hsu, MC Hung, J Biol Chem 2010 285 38720 38729 10.1074/jbc.M110.158659 20937808
20. EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis. RO Stuart, A Pavlova, D Beier, Z Li, Y Krijanovski, SK Nigam, Am J Physiol Renal Physiol 2001 281 1148 F1156 11704567
21. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. E Wallgard, E Larsson, L He, M Hellstrom, A Armulik, MH Nisancioglu, G Genove, P Lindahl, C Betsholtz, Arterioscler Thromb Vasc Biol 2008 28 1469 1476 10.1161/ATVBAHA.108.165738 18483404
22. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. K Vandal, P Rouleau, A Boivin, C Ryckman, M Talbot, PA Tessier, J Immunol 2003 171 2602 2609 12928412 (Pubitemid 37025572)
23. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. C Marsik, F Mayr, F Cardona, U Derhaschnig, OF Wagner, B Jilma, Br J Haematol 2003 121 653 656 10.1046/j.1365-2141.2003.04350.x 12752109 (Pubitemid 36645389)
24. Immunodepressive effects of LPS on monocyte CD14 in vivo. H Hojman, D Lounsbury, H Harris, JK Horn, J Surg Res 1997 69 7 10 10.1006/jsre.1997.5010 9202639 (Pubitemid 27265819)